Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $435,188 - $502,169
1,345 Added 4.78%
29,500 $11 Million
Q4 2022

Feb 13, 2023

BUY
$248.67 - $334.17 $2.15 Million - $2.89 Million
8,655 Added 44.38%
28,155 $9.3 Million
Q3 2022

Nov 10, 2022

SELL
$263.81 - $337.27 $263,810 - $337,270
-1,000 Reduced 4.88%
19,500 $5.15 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $872,758 - $976,442
-2,300 Reduced 10.09%
20,500 $8.56 Million
Q4 2021

Feb 11, 2022

BUY
$373.53 - $434.12 $448,235 - $520,944
1,200 Added 5.56%
22,800 $9.55 Million
Q3 2020

Nov 06, 2020

SELL
$280.08 - $347.78 $952,272 - $1.18 Million
-3,400 Reduced 13.6%
21,600 $7.28 Million
Q2 2020

Aug 13, 2020

SELL
$270.93 - $320.3 $54,186 - $64,060
-200 Reduced 0.79%
25,000 $7.09 Million
Q1 2020

May 14, 2020

SELL
$243.44 - $359.98 $389,504 - $575,968
-1,600 Reduced 5.97%
25,200 $6.95 Million
Q4 2019

Feb 14, 2020

SELL
$281.18 - $322.05 $365,534 - $418,665
-1,300 Reduced 4.63%
26,800 $8.61 Million
Q3 2019

Nov 01, 2019

SELL
$294.25 - $341.49 $588,500 - $682,980
-2,000 Reduced 6.64%
28,100 $8.35 Million
Q2 2019

Aug 02, 2019

SELL
$279.29 - $336.89 $474,793 - $572,713
-1,700 Reduced 5.35%
30,100 $10.1 Million
Q1 2019

May 02, 2019

SELL
$246.18 - $297.25 $4.01 Million - $4.85 Million
-16,300 Reduced 33.89%
31,800 $9.42 Million
Q4 2018

Jan 30, 2019

SELL
$232.7 - $281.66 $558,480 - $675,984
-2,400 Reduced 4.75%
48,100 $12.2 Million
Q3 2018

Nov 02, 2018

SELL
$236.3 - $277.15 $2.36 Million - $2.77 Million
-10,000 Reduced 16.53%
50,500 $14 Million
Q1 2018

May 09, 2018

BUY
$218.74 - $251.43 $218,740 - $251,430
1,000 Added 1.68%
60,500 $13.8 Million
Q4 2017

Feb 02, 2018

SELL
$217.88 - $244.43 $217,880 - $244,430
-1,000 Reduced 1.65%
59,500 $13 Million
Q3 2017

Nov 01, 2017

BUY
$231.6 - $253.39 $14 Million - $15.3 Million
60,500
60,500 $14.3 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.